PCI Biotech interim Q4 2022 results
Oslo (Norway), 17 February 2023 – PCI Biotech (OSE: PCIB), today announces its interim Q4 2022 results. Please find
Globe Newswire17-02-2023, 13:25
LyondellBasell enters into an agreement and exclusive negotiations with AEQUITA for the sale of four European Strategic Assessment assets 5-06-2025, 16:00